Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Stud... by Mikulski, Damian, Robak, Paweł, Ryżewska, Wiktoria, Stańczak, Kamila, Kościelny, Kacper, Góra-Tybor, Joanna, Robak, Tadeusz

Get full text

Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Robak, Tadeusz, Kasprzak, Jarosław D, Jesionek-Kupnicka, Dorota, Chudobiński, Cezary, Robak, Paweł

Get full text

Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma by Delimpasi, Sosana, Dimopoulos, Meletios A., Straub, Jan, Symeonidis, Argiris, Pour, Luděk, Hájek, Roman, Touzeau, Cyrille, Bhanderi, Viralkumar K., Berdeja, Jesus G., Pavlíček, Petr, Matous, Jeffrey V., Robak, Pawel J., Suryanarayan, Kaveri, Miller, Alison, Villarreal, Miguel, Cherepanov, Dasha, Srimani, Jaydeep K., Yao, Huilan, Labotka, Richard, Orlowski, Robert Z.

Get full text

Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study by Schjesvold, Fredrik H, Ludwig, Heinz, Delimpasi, Sossana, Robak, Pawel, Coriu, Daniel, Tomczak, Waldemar, Pour, Ludek, Spicka, Ivan, Dimopoulos, Meletios-Athanasios, Masszi, Tamas, Chernova, Natalia G, Sandberg, Anna, Thuresson, Marcus, Norin, Stefan, Bakker, Nicolaas A, Mateos, Maria-Victoria, Richardson, Paul G, Sonneveld, Pieter

Get full text

Older and new purine nucleoside analogs for patients with acute leukemias by Robak, Pawel, Robak, Tadeusz

Get full text

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma by Goldman‐Mazur, Sarah, Jurczyszyn, Artur, Castillo, Jorge J., Waszczuk‐Gajda, Anna, Grząśko, Norbert, Radocha, Jakub, Bittrich, Max, Kortüm, K. Martin, Gozzetti, Alessandro, Usnarska‐Zubkiewicz, Lidia, Davila Valls, Julio, Jayabalan, David S., Niesvizky, Ruben, Kelman, Julia, Coriu, Daniel, Rosiñol, Laura, Szukalski, Łukasz, González‐Calle, Veronica, Mateos, Maria V., Jamroziak, Krzysztof, Hus, Iwona, Avivi, Irit, Cohen, Yael, Suska, Anna, Chappell, Aimee, Madduri, Deepu, Chhabra, Saurabh, Kleman, Ariel, Hari, Parameswaran, Delforge, Michel, Robak, Paweł, Gentile, Massimo, Kozłowska, Izabela, Goldberg, Stuart L., Czepiel, Jacek, Silbermann, Rebecca, Olszewski, Adam J., Barth, Peter, Mikala, Gabor, Chim, Chor S., Długosz‐Danecka, Monika, Grosicki, Sebastian, Vesole, David H.

Get full text

Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens by Robak, Paweł, Szemraj, Janusz, Mikulski, Damian, Drozdz, Izabela, Juszczak, Karolina, Jarych, Dariusz, Misiewicz, Małgorzata, Kościelny, Kacper, Fendler, Wojciech, Robak, Tadeusz

Get full text

Drug resistance in multiple myeloma by Robak, Pawel, Drozdz, Izabela, Szemraj, Janusz, Robak, Tadeusz

Get full text

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases by Robak, Tadeusz, Korycka, Anna, Lech-Maranda, Ewa, Robak, Pawel

Get full text

Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma by Kubicki, Tadeusz, Dytfeld, Dominik, Barnidge, David, Sakrikar, Dhananjay, Przybyłowicz-Chalecka, Anna, Jamroziak, Krzysztof, Robak, Paweł, Czyż, Jarosław, Tyczyńska, Agata, Druzd-Sitek, Agnieszka, Giannopoulos, Krzysztof, Wróbel, Tomasz, Nowicki, Adam, Szczepaniak, Tomasz, Łojko-Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Szukalski, Łukasz, Końska, Agnieszka, Zaucha, Jan Maciej, Walewski, Jan, Mikulski, Damian, Czabak, Olga, Robak, Tadeusz, Jiang, Ken, Cooperrider, Jennifer H., Jakubowiak, Andrzej J., Derman, Benjamin A.

Get full text

Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib by Mikulski, Damian, Robak, Paweł, Perdas, Ewelina, Węgłowska, Edyta, Łosiewicz, Aleksandra, Dróżdż, Izabela, Jarych, Dariusz, Misiewicz, Małgorzata, Szemraj, Janusz, Fendler, Wojciech, Robak, Tadeusz

Get full text

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study by Moreau, Philippe, Pylypenko, Halyna, Grosicki, Sebastian, Karamanesht, Ievgenii, Leleu, Xavier, Rekhtman, Grigoriy, Masliak, Zvenyslava, Robak, Pawel, Esseltine, Dixie-Lee, Feng, Huaibao, Deraedt, William, van de Velde, Helgi, Arnulf, Bertrand

Get full text

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients by Goldman-Mazur, Sarah, Jurczyszyn, Artur, Castillo, Jorge J., Waszczuk-Gajda, Anna, Grząśko, Norbert, Radocha, Jakub, Bittrich, Max, Kortüm, Klaus Martin, Gozzetti, Alessandro, Usnarska-Zubkiewicz, Lidia, Valls, Julio D., Jayabalan, David S., Niesvizky, Ruben, Kelman, Julia, Coriu, Daniel, Rosiñol, Laura, Szukalski, Łukasz, González-Calle, Veronica, Mateos, María-Victoria, Jamroziak, Krzysztof, Hus, Iwona, Avivi, Irit, Cohen, Yael, Mazur, Piotr, Suska, Anna, Chappell, Aimee, Madduri, Deepu, Chhabra, Saurabh, Kleman, Ariel, Hari, Parameswaran, Delforge, Michel, Robak, Paweł, Gentile, Massimo, Kozłowska, Izabela, Goldberg, Stuart L., Czepiel, Jacek, Długosz-Danecka, Monika, Silbermann, Rebecca, Olszewski, Adam J., Barth, Peter, Mikala, Gabor, Chim, Chor S., Vesole, David H.

Get full text

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis by Chyra, Zuzana, Sevcikova, Tereza, Vojta, Petr, Puterova, Janka, Brozova, Lucie, Growkova, Katerina, Filipova, Jana, Zatopkova, Martina, Grosicki, Sebastian, Barchnicka, Agnieszka, Jedrzejczak, Wieslaw Wiktor, Waszczuk-Gajda, Anna, Jungova, Alexandra, Mikulasova, Aneta, Hajduch, Marian, Mokrejs, Martin, Pour, Ludek, Stork, Martin, Harvanova, Lubica, Mistrik, Martin, Mikala, Gabor, Robak, Pawel, Czyz, Anna, Debski, Jakub, Usnarska-Zubkiewicz, Lidia, Jurczyszyn, Artur, Stejskal, Lukas, Morgan, Gareth, Kryukov, Fedor, Budinska, Eva, Simicek, Michal, Jelinek, Tomas, Hrdinka, Matous, Hajek, Roman

Get full text

Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development by Rogalińska, Małgorzata, Góralski, Paweł, Błoński, Jerzy Z, Robak, Paweł, Barciszewski, Jan, Koceva-Chyła, Aneta, Piekarski, Henryk, Robak, Tadeusz, Kilianska, Zofia M

Get full text

BCR Signaling in Chronic Lymphocytic Leukemia and Related Inhibitors Currently in Clinical Studies by Robak, Tadeusz, Robak, Pawel

Get full text

Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study by Jurczyszyn, Artur, Nahi, Hareth, Avivi, Irit, Gozzetti, Alessandro, Niesvizky, Ruben, Yadlapati, Sujitha, Jayabalan, David S., Robak, Paweł, Pika, Tomas, Andersen, Kristian T., Rasche, Leo, Mądry, Krzysztof, Woszczyk, Dariusz, Raźny, Małgorzata, Usnarska‐Zubkiewicz, Lidia, Knopińska‐Posłuszny, Wanda, Wojciechowska, Małgorzata, Guzicka‐Kazimierczak, Renata, Joks, Monika, Grosicki, Sebastian, Ciepłuch, Hanna, Rymko, Marcin, Vesole, David H., Castillo, Jorge J.

Get full text

Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases by Rogalińska, Małgorzata, Franiak-Pietryga, Ida, Błoński, Jerzy Z., Góralski, Paweł, Maciejewski, Henryk, Janus, Agnieszka, Robak, Paweł, Mirowski, Marek, Piekarski, Henryk, Robak, Tadeusz, Kiliańska, Zofia M.

Get full text

Preemptive Daratumumab Therapy for Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma: Rationale and Design of the Polish Myeloma Consortium Predator... by Jamroziak, Krzysztof, Giannopoulos, Krzysztof, Wrobel, Tomasz, Nowicki, Adam, Pula, Bartosz, Grząśko, Norbert, Rybka, Justyna, Robak, Paweł J., Druzd-Sitek, Agnieszka, Walter-Croneck, Adam, Brzeźniakiewicz-Janus, Katarzyna, Czyż, Jarosław, Warzocha, Krzysztof, Dytfeld, Dominik

Get full text

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group by Paszkiewicz-Kozik, Ewa, Dlugosz-Danecka, Monika, Robak, Paweł J., Wojciechowska-Lampka, Elżbieta, Swierkowska-Czeneszew, Monika, Tajer, Joanna, Romejko-Jarosinska, Joanna, Domanska-Czyz, Katarzyna, Szymanski, Marcin, Morawska, Marta, Targonski, Lukasz, Osowiecki, Michal, Ostrowska, Beata, Dabrowska-Iwanicka, Anna Paulina, Walewski, Jan

Get full text